American Society of Breast Disease, Frisco, TX 75034, United States.
Breast. 2010 Aug;19(4):260-7. doi: 10.1016/j.breast.2010.03.013.
Recent suggestions by the United States Preventive Task Force to change the longstanding guidelines for screening mammography have raised the issue of cost-effectiveness in regards to breast cancer detection. Given the enormous number of women who have had, or who will be diagnosed with breast cancer, it is essential to maintain the quality of care that has been achieved here in the United States while utilizing a cost-effective approach. The following review attempts a close examination of current methods available for risk assessment, screening and prevention programs. These programs must be carefully considered and analyzed prior to implementing cost-saving changes to current clinical standards that have proven successful in decreasing the mortality from breast cancer throughout the world.
最近，美国预防工作组提出改变长期以来的乳腺癌筛查指南，这引发了乳腺癌检测的成本效益问题。鉴于已经或将要被诊断出患有乳腺癌的女性数量巨大，在美国保持已经取得的护理质量至关重要，同时还需要采用具有成本效益的方法。以下综述试图对当前可用于风险评估、筛查和预防计划的方法进行仔细检查。在对目前已被证明能降低全球乳腺癌死亡率的成功的临床标准进行节省成本的改变之前，这些方案必须经过仔细考虑和分析。
